Fig. 5

The prognostic value of TS score in BLCA. A, C, E, and G Kaplan–Meier curves for low and high TS score groups in TCGA BLCA cohorts (A). Log-rank test, p = 0.002; in GSE32894 cohort (C). Log-rank test, p < 0.001; in GSE13507 cohort (E). Log-rank test, p = 0.004; and in E-MTAB-4321 cohort (G). Log-rank test, p = 0.003. B, D, F, and H The ROC analysis of TS score in TCGA BLCA cohorts (B). AUC = 0.652, 0.660, and 0.660 at 1, 3, and 5 year; in GSE32894 cohort (D). AUC = 0.831, 0.841, and 0.851 at 1, 3, and 5 year; in GSE13507 cohort (F). AUC = 0.761, 0.673, and 0.616 at 1, 3, and 5 year; and in GSE13507 cohort (H). AUC = 0.718, 0.730, and 0.679 at 1, 3, and 5 year. I The meta-analysis of the TS score’s HR in three cohorts. J The nomogram based on TS score and clinical variates. K Calibration curve of the nomogram in TCGA BLCA cohorts